CBS Report Brings to Light the Ugly Truth on the Yamaha Rhino

A CBS Special Report has finally brought to light the outrage surrounding the Yamaha Rhino. According to the Consumer Product Safety Commission (CPSC), more than 59 riders have been killed in accidents involving the Yamaha Rhino, an all terrain vehicle guilty of a seriously flawed design. A staggering 440 wrongful death and personal injury lawsuits are pending against Yamaha for accidents involving the Rhino, and that does not include lawsuits they have already decided to settle. For years, Yamaha has done their best to avoid public humiliation and increased legal pressure regarding the Rhino, however recent pressure from the CPSC has brought the matter to the attention of the public.

The consequences of poor design and lack of safety standards applied to the Rhino has had staggering consequences. Hundreds upon hundreds of cases have surfaced describing accidents involving crushed legs and arms, amputations, head trauma, and in far too many cases, even death.

So where does the problem stem from? Thanks to the extensive work of plaintiff’s attorneys and the experts that aide them, two fatal flaws have been discovered in the design of the Rhino. Almost all accidents involving the Rhino result from rollovers and full or partial ejection from the vehicle. Rollovers are reported to have been the result of a high center of gravity mixed with a shallow wheel base. This has resulted in rollovers even at low speeds and on flat terrain. Once the vehicle has begun to roll, injury becomes almost unavoidable, as the Rhino contains no safety restraint system, and does not include any doors which keep operators and their limbs inside the vehicle during a rollover. The results of these two design flaws has obviously been catastrophic.

Despite the overwhelming evidence, Yamaha’s response has been to deny until death. After being pressured by the CPSC to recall the product, Yamaha responded by announcing a , “free repair program,” to improve the Rhino’s handling and stability-seemingly a recall in everything but name. The company agreed to install spacers on the rear axles of the vehicles to make them a few inches wider, to remove their rear anti-sway bars, and install protective half-doors on Rhinos that don’t already have them. Owners who watch a safety video when they bring in their Rhinos will also get a $100 coupon toward purchase of a helmet. Yamaha stressed that the action was not a recall, but a, “voluntary repair program.” By avoiding the term, “recall,” Yamaha is attempting to protect itself from legal punitive damages, which has upset many agency officials and consumers.

While the evidence seems undeniable, Yamaha’s extensive legal team is making life as difficult as possible for the families of wrongfully injured or killed consumers. The problem comes from proving causation. Jurors have to be convinced that it was the design of the ATV, not driver error that caused the accident and resulting injuries. While accident reconstructions and expert testimony clearly point to faulty design, Yamaha’s attorneys have attacked its own customers by alleging improper use and dangerous driving. However, much to Yamaha’s avail, some cases brought regard drivers that are not doing anything irresponsibly. They are not going too fast, traveling on level ground, and not turning hard. They still roll over and because of lack of restraint systems these drivers and passengers are subjected to incredible injuries.

While it appears to be a long and difficult road ahead, the side of consumer safety and protection will eventually prevail. Plaintiff’s attorneys are continuing the fight to have the product entirely recalled and make sure the victims of faulty design are compensated for their pain and suffering. If you or anyone you know owns one of these vehicles, please inform them of the dangers immediately, and advise them to cease using it. Finally, if you, your family, or a friend has been a victim of an accident involving the Yamaha Rhino, please contact an attorney immediately. The only way to get Yamaha to right the situation is to press them legally. Each new case against Yamaha involving the Rhino send the message to corporations that the public demands safety be the top priority of vehicle design.

Contact an Attorney in New Jersey
Contact an Attorney in Pennsylvania

Medical Research Continues to Lose Integrity

Senator Charles E. Grassley has raised some serious concern over a recent article published in the Elsevier Medical Journal. The Senator has asked the publisher to investigate an article written on hormone replacement therapy, believing that it was improperly “ghostwritten” by a drug company promoting their products. The article was part of an editor’s choice section in Elsevier’s Journal of Obstetrics and Gynecology.

In an article signed by Dr. John Eden of Australia, Senator Grassley has found unethical promotions lacking scientific evidence. At the heart of the controversy is the drug company Wyeth. Mr. Grassley, a member of the Senate Finance Committee who is investigating drug company influence on doctors, contends that Wyeth commissioned the articles and had them ghostwritten by a medical writing firm. Only after the articles were conceived and under way did the firm line up doctors to put their names on them, Mr. Grassley contends.

Unfortunately, this is not an isolated incident. Drug companies have been forcing their will on medical research results for decades now, and the influence of corporate profit is on the rise. By 2006, Drug companies were spending nearly twice as much on advertising and marketing as they were on the research and testing needed to ensure the safety of a new product.

Mr. Grassley’s investigation shows how results of this corporate policy can be catastrophic. A landmark federal study has linked Wyeth’s Prempro hormone product to breast cancer in women. What does the expert testimony sponsored by Wyeth say about that taxpayer funded study? Dr. Eden’s controversial article states that, “there was no definitive evidence that the [Wyeth] hormones caused breast cancer.”

It seems the Wyeth Corporation and Dr. Eden have forgotten the meaning of the Hippocratic oath.

Contact a Medical Malpractice Attorney in PA

Contact a Medical Malpractice Attorney in NJ

Morphine, Dextroamphetamine, and Isosorbide added to the Ethex Recall

The Ethex Corporation has added three new drugs to its list of recently recalled products.  After Ethex discovered that their propafenone tablets were over-sized, it became evident that many other drugs being manufactured by the company were also over-sized. 

Isosorbide

Isosorbide is a drug used principally in the treatment of angina. It works by dilating the blood vessels in order to reduce blood pressure. All of the recalled Isosorbide Mononitrate tablets said they were 60mg on the bottle and were made by the ETHEX Corporation with expiration dates ranging from 12/2008 and 11/2009.

Recalled lot numbers: 63466, 66034, 67351, and 67354

Dextroamphetamine

Dextroamphetamine is a stimulant used to increase energy and decrease appetite.  The recalled Dextroamphetamine Sulfate came in 10mg pills with expiration dates ranging from 6/2009 to 5/2007. All were made by the ETHEX Corporation.

Recalled lot numbers: 73934, 75892, 77945, 81137, 86320.

Amphetamines are very dangerous drugs, especially when taken in excessive doses. If the batch number on your pill bottle matches any of the above recalled Dextroamphetamine batch numbers you should contact your doctor and/or pharmacists immediately.

Morphine

Two strengths of immediate release Morphine Sulfate and one strength of extended release Morphine Sulfate were recalled, all of them tablets made by the ETHEX Corporation. The two recalled Morphine immediate release pills were 15mg and 30mg. The recalled Morphine extended release pills were 15mg.  The recalled tablets come from any of the following lots with expiration dates ranging from 8/2009 to 3/2011.

Recalled Lot Numbers:

15mg Extended Release Morphine – 81175, 82514-16, 89660, 89664, 89667, 90249-51, 91687
15mg Immediate Release Morphine – 77852-54, 81746, 82519-20, 84113, 90276-78
30mg Immediate Release Morphine – 75093, 77855-57, 82297, 82521-22, 87239, 88925, 90288-98

Morphine is a highly potent and addictive drug in the opiate family. Like other opioids, such as heroin, morphine acts on the central nervous system to relieve pain. Morphine is highly addictive. Tolerance, physical and psychological dependence develops very rapidly. Overdosing on Morphine is very dangerous and can result in severe side effects, including death.

 If you or anyone you know is prescribed any of these drugs, please immediately check the manufacturer and lot number on your pill bottle.  Contact your physician immediately.  Even in the case that you don’t think you have a recalled prescription; call your pharmacy and physician to confirm. 

 If you or a family member has been hurt by any of the Ethex Corporation recalled drugs, please contact an attorney immediately.  You may be entitled to compensation. 

 Contact a Medical Malpractice Attorney in PA

 Contact a Medical Malpractice Attorney in NJ